Therapeutic drug monitoring of TNFinhibitors and other therapeutic antibodies.
Develop assays for novel immunotherapy drugs such as pembrolizumab, nivolumab and ipilimumab for monitoring drug levels in patients with lung cancer and malignant melanoma.
Develop assays for measuring rituximab and anti-rituximab for monitoring drug level and anti-drug antibody formation.
Detection of antibodies to transglutaminase in the HUNT4-cohort using an in-house dual label assay in collaborative study “Coeliac disease in HUNT”.
Screening for patient antibodies to HH1, a novel antibody-based drug used in lymphoma clinical trials (Lymrit).
Lukina P, Andersen IL, Klaasen RA, Warren DJ, Bolstad N, Mjønes P, Rønne E, Iversen R, Sollid LM, Lundin KEA, Ness-Jensen E(2024) The prevalence and rate of undiagnosed celiac disease in an adult general population, the Trøndelag Health Study, Norway Clin Gastroenterol Hepatol(in press) DOI 10.1016/j.cgh.2024.06.027, PubMed 38987013
Nome RV, Paus E, Gehin JE, Bolstad N, Bjøro T(2024) Managing hemolysis in serum neuron-specific enolase measurements - an automated algorithm for routine practice Scand J Clin Lab Invest, 1-5(in press) DOI 10.1080/00365513.2024.2359091, PubMed 38853575
Hansen TC, Tully TN, John Mathews V, Warren DJ(2024) A Multimodal Assistive-Robotic-Arm Control System to Increase Independence After Tetraplegia IEEE Trans Neural Syst Rehabil Eng, 32, 2124-2133 DOI 10.1109/TNSRE.2024.3408833, PubMed 38829756